Company: NCEL
Filing Date: 2025-10-24
Form Type: POS AM
Source: 0001213900-25-102149
Chunk: 74

Company: NewcelX Ltd.
Filing Date: 2025-10-24
Form: POS AM
Chunk 74
---
 Registration Statement on Form F-4 filed on September 3, 2025).     |
| 2.8            |     | Amendment No. 7 to Agreement and Plan of Merger, dated as of August 29, 2025, by and among NLS Pharmaceutics Ltd., NLS Pharmaceutics (Israel) Ltd. and Kadimastem Ltd. (included as Annex A to the proxy statement/prospectus on Registration Statement on Form F-4 filed on September 3, 2025).   |
| 3.1            |     | Amended and Restated Articles of Association of NLS Pharmaceutics Ltd. (filed as Exhibit 99.1 to Form 6-K (File No. 001-39957) filed on November 15, 2024).                                                                                                                                        |
| 5.1            |     | Opinion of Baker McKenzie AG, Swiss counsel to NLS Pharmaceutics Ltd. (filed as Exhibit 5.1 to Form F-1 filed on September 25, 2025).                                                                                                                                                              |
| 10.1           |     | Common Shares Purchase Agreement, dated March 30, 2025, between NLS Pharmaceutics and Alpha Capital Anstalt (filed as Exhibit 99.3 to Form 6-K (File No. 001-39957) filed March 31, 2025).                                                                                                         |
| 10.2           |     | Form of Pre-Funded Warrant (filed as Exhibit 99.4 to Form 6-K (File No. 001-39957) filed March 31, 2025).                                                                                                                                                                                          |
| 23.1*          |     | Consent of PricewaterhouseCoopers AG.                                                                                                                                                                                                                                                              |
| 23.2*          |     | Consent of Marcum LLP.                                                                                                                                                                                                                                                                             |
| 23.3*          |     | Consent of Kost Forer Gabbay & Kasierer, a member of EY Global.                                                                                                                                                                                                                                    |
| 24.1           |     | Power                                                                                                                                                                                                                                                                                              
 of Attorney (included on signature page to the Form F-1 filed on September 25, 2025).                                                                                                                                                                                                              |

| * | Filed herewith |

<div align='center'>II-4</div>

Item 9. Undertakings

| (a) | The undersigned Registrant hereby undertakes: |

| (1) |